The experience of weight gain as a result of taking second-generation antipsychotic medications: the mental health consumer perspective

被引:29
|
作者
Usher, K. [1 ]
Park, T. [1 ]
Foster, K. [2 ]
机构
[1] James Cook Univ, Sch Nursing Midwifery & Nutr, Cairns, Qld 4870, Australia
[2] Univ Sydney, Sydney Nursing Sch, Camperdown, NSW, Australia
关键词
medication management; mental health; psychotropic medications; qualitative methodology; weight gain; SCHIZOPHRENIA; BARRIERS; ILLNESS;
D O I
10.1111/jpm.12019
中图分类号
R47 [护理学];
学科分类号
1011 ;
摘要
This interpretive qualitative study aimed to describe and construct the meaning of the experience of living with the weight gain associated with second-generation antipsychotics. A qualitative study that incorporated the tenets of phenomenology and utilized in-depth interviews was conducted with eight mental health consumers. Thematic analysis resulted in three themes: Grappling with the weight; Living with the consequences of being overweight; and Experiencing negative emotions about the weight gain. The findings indicate that consumers struggle to manage the insatiable appetite and the related weight gain associated with second-generation antipsychotic medication, as well as the numerous associated physical and emotional issues. Adherence with prescribed second-generation antipsychotic medication was also affected and a number of the participants indicated they had ceased or considered ceasing their medication because of the weight gain associated with the drugs.
引用
收藏
页码:801 / 806
页数:6
相关论文
共 50 条
  • [1] Weight gain and diabetes with "second-generation" antipsychotic drugs
    Firestone, A
    [J]. MEDICAL JOURNAL OF AUSTRALIA, 2005, 182 (12) : 652 - 653
  • [2] Second-generation antipsychotic medications in children and adolescents
    Cheng-Shannon, J
    McGough, JJ
    Pataki, C
    McCracken, JT
    [J]. JOURNAL OF CHILD AND ADOLESCENT PSYCHOPHARMACOLOGY, 2004, 14 (03) : 372 - 394
  • [3] Dosing equivalency of second-generation antipsychotic medications
    Buckley, PF
    [J]. JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY, 2005, 25 (05) : 501 - 502
  • [4] Weight Gain Effects of Second-Generation Antipsychotic Treatment in Autism Spectrum Disorder
    Yoon, Yesie
    Wink, Logan K.
    Pedapati, Ernest V.
    Horn, Paul S.
    Erickson, Craig A.
    [J]. JOURNAL OF CHILD AND ADOLESCENT PSYCHOPHARMACOLOGY, 2016, 26 (09) : 822 - 827
  • [5] The role of ghrelin signalling in second-generation antipsychotic-induced weight gain
    Zhang, Qingsheng
    Deng, Chao
    Huang, Xu-Feng
    [J]. PSYCHONEUROENDOCRINOLOGY, 2013, 38 (11) : 2423 - 2438
  • [6] Reply to "Dosing equivalency of second-generation antipsychotic medications"
    Davis, JM
    Chen, N
    [J]. JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY, 2005, 25 (05) : 502 - 503
  • [7] PERSISTENT HYPERGLYCEMIA SECONDARY TO SECOND-GENERATION ANTIPSYCHOTIC MEDICATIONS
    Arrese, N. Soulages
    Middleman, A. B.
    Meyer, J. D.
    [J]. JOURNAL OF INVESTIGATIVE MEDICINE, 2018, 66 (02) : 382 - 383
  • [8] Second-Generation Antipsychotic Medications and Risk of Pneumonia in Schizophrenia
    Kuo, Chian-Jue
    Yang, Shu-Yu
    Liao, Ya-Tang
    Chen, Wei J.
    Lee, Wen-Chung
    Shau, Wen-Yi
    Chang, Yao-Tung
    Tsai, Shang-Ying
    Chen, Chiao-Chicy
    [J]. SCHIZOPHRENIA BULLETIN, 2013, 39 (03) : 648 - 657
  • [9] Second-generation antipsychotic medications and metabolic disturbance in children and adolescents
    Makary, Samy
    Abd El Moez, Khaled
    Elsayed, Mona
    Hassan, Haydy
    [J]. EGYPTIAN JOURNAL OF NEUROLOGY PSYCHIATRY AND NEUROSURGERY, 2023, 59 (01):
  • [10] Recent studies on the neurocognitive effects of second-generation antipsychotic medications
    Green, MF
    [J]. CURRENT OPINION IN PSYCHIATRY, 2002, 15 (01) : 25 - 29